Is Celon Pharma S.A. stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Celon Pharma S.A. pays dividends. Last time was Thursday 4th of July 2024 where the investors holding the stock on Thursday 27th of June 2024 were paid PLN0.08 per share. Over the last 8 times between 2017 and 2024, Celon Pharma S.A. has paid PLN1.19 with an average of PLN0.15 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Celon Pharma S.A. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was PLN40.15, you would have made a loss of PLN-12.00 per share or -29.89%
Yes, the average daily trading liquidity for Celon Pharma S.A. is PLN153 293 thousand. You should therefore be able to get in and out of your positions relatively fast.
Celon Pharma S.A. has no real debt, which is good in periods of high inflation. With a low cash flow to debt ratio of 0.09, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Celon Pharma S.A. to be medium [0.6 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.